News & Articles
Selected Filters:
Unyvero AMR Atlas to Support Adoption of Rapid DNA Testing for Antibiotic Resistance
The Unyvero Platform allows rapid testing for a broad range of pathogens and antibiotic resistance markers associated with life-threatening infections in hospitalized patients
Troubleshoot Your Mass Spec Workflow and Earn CE Credits
Dr. Heather Brown discusses how to iron out variability in dried blood spot analysis with FIA-MS/MS
Clinical Highlights: Three-Person Babies, AI for Cancer Diagnostics & Automation Advances
Catch up on all the biggest stories and top downloadable content in the clinical community in our monthly round-up
New Blood Test for TB Enters Clinical Trials
UK researchers hope rapid Actiphage® test could improve TB screening
Trimix Advances to Next Stage in Clinical Trials
The tripartite mRNA technology has completed its phase 1b study for direct, intranodal injections in adjuvant melanoma patients
Landmark Dual CE Mark Granted to Hologic's Aptima in HIV-1 Diagnosis
The certification indicates that the Aptima is the first and only diagnostic tool to incorporate both viral load and early infant diagnosis
Artificial Intelligence Increases Diagnostic Rates in Surviving Ovarian Cancer Patients
New machine learning software can forecast the survival rates and response to treatments of patients with ovarian cancer
Oxford University Scientists Catch Heartbeat ‘Molecular Switch’ in Action
Calcium flow tracked in heart muscle fibres in real time
Fundamental Technology to Support the Early Diagnosis of Neurodevelopmental Disorders from Brain Response at First Medication
Optical topography to reduce patient burden in the treatment of attention-deficit hyperactivity disorder
New Partnership Extends Reach of Hematopoietic Primary Cells Portfolio
Lonza and AllCells team up to offer an extensive range of hematopoietic primary cells to reach the global scientific community
Heart Failure: Diagnosis, Causes & Latest Treatments
Dr. Jim Aguanno explores the role of natriuretic peptides – NT-proBNP and BNP – in the diagnosis of heart failure
Horizon Discovery extends CRISPR Screening Service to Primary Human T cells
Extended screening service offers novel capabilities for immuno-oncology research in ex vivo T lymphocytes
























